about
Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania.Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-TanzaniaPrevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Skin cancers among Albinos at a University teaching hospital in Northwestern Tanzania: a retrospective review of 64 cases.Prevalence and factors associated with Group A rotavirus infection among children with acute diarrhea in Mwanza, Tanzania.Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania.Multi-resistant gram negative enteric bacteria causing urinary tract infection among malnourished underfives admitted at a tertiary hospital, northwestern, Tanzania.Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, Tanzania.Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.Predictors of outcome among patients with obstructive jaundice at Bugando Medical Centre in north-western Tanzania.High prevalence of Plasmodium falciparum pfcrt K76T mutation in children with sickle cell disease at a tertiary hospital in north-western Tanzania.Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania.Complications of sickle cell anaemia in children in Northwestern Tanzania.Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.Malaria among adult inpatients in two Tanzanian referral hospitals: a prospective study.Predominance of methicillin resistant Staphylococcus aureus -ST88 and new ST1797 causing wound infection and abscesses.Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.High birth prevalence of sickle cell disease in Northwestern Tanzania.Albinism and disease causing pathogens in Tanzania: are alleles that are associated with OCA2 being maintained by balancing selection?Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia.Self-medication among pregnant women attending antenatal clinic at Makongoro health centre in Mwanza, Tanzania: a challenge to health systems.Why some sites are responding better to anti-malarial interventions? A case study from western Kenya.The current malaria morbidity and mortality in different transmission settings in Western KenyaUtility of passive malaria surveillance in hospitals as a surrogate to community infection transmission dynamics in western KenyaEfficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland TanzaniaEfficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
P50
Q33422589-ABB4FBCD-8DC0-4642-A302-CDA24F58CA39Q33595291-1BBB7283-F632-41DC-B5E5-4084FE11D19FQ33781469-2AEC5BF9-919F-48D2-A53C-0B5FE3293410Q34281680-F1585A48-F8B2-416F-BB1C-570BDD475942Q34297689-3993DCAB-5330-418E-8133-9AFD59AD468FQ34307099-A02494DB-8F98-49A4-988F-C60FCFC1BD28Q34491448-2DB78E7E-4562-4204-8AB9-CFB8EC0A7749Q34538061-C31CE5B3-9CEC-49E2-84F6-B74549284674Q35675056-843AD2E0-4C3B-4D84-B7CD-3E53E0E983AFQ35755856-18680D1D-3D38-4814-9A4F-BBA754BD4EB1Q35805829-F9F5A6AC-2483-4F33-8206-A864FC423CF6Q35830639-3A41A083-7400-4B8A-BE79-F4365D5F7BCDQ35833995-4D5A5C6E-42D4-47EE-B40F-5F56A2B290C1Q35848003-A3951904-C5D5-4DDE-944D-0883EB34993AQ35927591-42D7E8A7-4037-4EC8-9B4D-3681573C3089Q36258077-5FBFB546-3122-4EC0-BCBC-E54D425BA35BQ37149765-ABD58060-5111-447B-BD93-A05CC9FF73CDQ38868907-5377438E-B602-4C8D-9991-EEB7EDC48A5FQ38871071-9BECA613-74B2-4E3C-AA0C-53BC402532E0Q39136195-4EE729CA-C693-4284-8114-D3C3756403B1Q39565807-32111289-2FAC-4B66-9F7E-D48CC24CD485Q43923925-275ADA44-DF56-4629-A4FD-900C9E2ADCEDQ43924913-D09A567A-CFC6-4162-AA84-C0D064C3ED51Q43938241-CFD0281B-4A01-4E67-8037-3C8D3BE0BD61Q46790648-AE0C18C1-03B1-4626-86E9-3B3B63E75A5AQ47178346-0A8C368F-DAB7-4858-8568-576322A95A9CQ47238075-20EFD442-3964-4CA2-8ECD-D0553E6DCA1EQ56345623-057577F1-5D86-4CCA-ABC4-4A97A01193E7Q56355813-AC35EA41-F9D5-4D54-9DC9-F83CBB83AC65Q58546525-B1862942-1DB5-4DB2-B73C-AE056E1BEC60Q64066462-90581301-F6DF-4FE2-876C-78CD1882AD59
P50
name
Erasmus Kamugisha
@en
Erasmus Kamugisha
@nl
type
label
Erasmus Kamugisha
@en
Erasmus Kamugisha
@nl
prefLabel
Erasmus Kamugisha
@en
Erasmus Kamugisha
@nl